ResMed | RMD - Net Income



ResMed reported $379.7M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Ansell USD 57.1M 37.7M Jun/2024
AtriCure USD -6190000 557K Jun/2025
Baxter International USD 91M 35M Jun/2025
Cochlear AUD 205.1M 39.7M Dec/2024
Cooper Companies USD 98.3M 10.6M Jul/2025
CSL USD 2.01B 1.27B Dec/2024
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 333.2M 24.8M Jun/2025
Fisher Paykel Healthcare NZD 112M 41.2M Mar/2025
Globus Medical USD 202.85M 127.38M Jun/2025
Haemonetics USD 34.03M 23.95M Jun/2025
Hologic USD 194.9M 212.3M Jun/2025
Idexx Laboratories USD 293.99M 51.31M Jun/2025
Insulet USD 22.5M 12.9M Jun/2025
Integra LifeSciences USD -484073000 458.78M Jun/2025
Intuitive Surgical USD 658.4M 40M Jun/2025
Masimo USD 51.3M 222M Jun/2025
Medtronic USD 1.04B 17M Jul/2025
Philips EUR 240M 165M Jun/2025
Ramsay Health Care AUD -104900000 235.1M Dec/2024
ResMed USD 379.7M 14.66M Jun/2025
Sigma Healthcare AUD 3.72M 10.44M Jul/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 177.4M 31.73M Jun/2025
Teleflex USD 122.58M 27.58M Jun/2025
Thermo Fisher Scientific USD 1.62B 110M Jun/2025